GGrantIndex
← Search

CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS

$658,770FY2018Defense Health AgencyDOD

Fundacio Privada Institut D Investigacio Oncologica De Vall-Hebron

Investigators

View source on USAspending →